- Видео 1 242
- Просмотров 129 201
Life Science Connect
США
Добавлен 14 янв 2020
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.
Why Tal Zaks Believes That Innovation Is Driven By Curiosity
Exsilio Therapeutics’ CEO Tal Zaks, previously CMO at Moderna, explains his philosophy that scientific curiosity is fundamental to groundbreaking drug development.
An excerpt from "Biotech Story Time With Tal Zaks, M.D. (Part 1)" - check out the full video at www.bioprocessonline.com/doc/biotech-story-time-with-tal-zaks-m-d-part-0001
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4
Spotify - open.spotify.com/show/5NhjpDeHzVlXPVqT9ezKwA
RUclips - ruclips.net/p/PLFXsCNKV78rWNPmqIA8b2dKYLPYYv28wb
An excerpt from "Biotech Story Time With Tal Zaks, M.D. (Part 1)" - check out the full video at www.bioprocessonline.com/doc/biotech-story-time-with-tal-zaks-m-d-part-0001
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4
Spotify - open.spotify.com/show/5NhjpDeHzVlXPVqT9ezKwA
RUclips - ruclips.net/p/PLFXsCNKV78rWNPmqIA8b2dKYLPYYv28wb
Просмотров: 11
Видео
Dr. Tal Zaks Reflects On The Moderna Era
Просмотров 162 часа назад
Dr. Zaks describes Moderna’s pre-COVID-19 mRNA research that prepared them for the frontlines of pandemic vaccine development. An excerpt from "Biotech Story Time With Tal Zaks, M.D. (Part 1)" - check out the full video at www.bioprocessonline.com/doc/biotech-story-time-with-tal-zaks-m-d-part-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/pod...
Dr. Tal Zaks’ Drive To Improve Patients’ Lives
Просмотров 72 часа назад
Exsilio Therapeutics’ CEO Tal Zaks was Moderna’s CMO during the creation of the COVID-19 vaccine, but he has also served patients as a physician, scientist, investor, and biotech builder. An excerpt from "Biotech Story Time With Tal Zaks, M.D. (Part 1)" - check out the full video at www.bioprocessonline.com/doc/biotech-story-time-with-tal-zaks-m-d-part-0001 #businessofbiotech #biopharma #biotec...
Preparing A Gap Analysis
Просмотров 112 часа назад
Ahead of a tech transfer, conducting a gap analysis or gap assessment is critical to ensure a smooth transfer of methods. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, Stephan Krause, Ph.D., and William Janssen, Ph.D., discuss the importance of performing gap assessments, which should start with a master plan that accounts for changes in equip...
Controlling Analyst Bias
Просмотров 12 часа назад
Panelist Cheryl Cox responds to an audience question about controlling analyst bias and gating for flow cytometry. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Keys To A Successful Tech Transfer
Просмотров 22 часа назад
Transferring analytical methods can be challenging, especially with manual processes, which can have more nuance to their conduct outside of an SOP. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists discuss the best way to approach the transfer of analytical methods and the importance of good communication when doing so. Check out th...
Phase-Appropriate Risk Management Strategies
Просмотров 12 часа назад
Panelist Cheryl Cox addresses an audience question about risk management strategy and assessing product safety throughout development. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Method Qualification Versus Method Validation
Просмотров 42 часа назад
Stephan Krause, Ph.D., responds to an audience question about the difference between method qualification and method validation in terms of activities. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Considerations For Characterization Assays And Release Testing
Просмотров 22 часа назад
Panelist Stephan Krause, Ph.D., from Bristol Meyers Squibb shares his thoughts on characterization assays and release testing, noting the unique patient-specific quality attributes inherent in autologous products. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Developing Safety And Potency Assays
Просмотров 52 часа назад
When it comes to potency assays, you should develop and validate them as early as possible. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists weigh in on key considerations for potency assay development. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Balancing Quick Results And Careful Planning
Просмотров 62 часа назад
In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists answer an audience question about how to navigate fast-paced development thoughtfully, which is especially critical for startups operating on a lean budget. Check out the full webinar available on-demand - www.bioprocessonline.com/doc/designing-transferable-analytical-methods-0001
Defining A Good Method Development Strategy
Просмотров 62 часа назад
In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists explain the importance of phase-appropriate analytical development and define what a good analytical method development strategy looks like. They agree that it’s important to address any deficiencies early in development to avoid problems in later-stage tech transfers. Check out the f...
Biotech Story Time With Tal Zaks, M.D. (Part 2)
Просмотров 1554 часа назад
Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during the COVID 19 pandemic to learn about his latest venture, an mRNA startup called Exsilio Therapeutics. We cover the foundational aspects of the company's start, from the science it's developing, wh...
Water Online Video Overview
Просмотров 139 часов назад
For nearly 30 years, Water Online has been the premier platform connecting water and wastewater technology suppliers with professionals across municipal and industrial markets. We empower marketers to overcome growth challenges and achieve measurable ROI through targeted audience access and content syndication. From custom microsites and newsletters to webinars, virtual events, and retargeting ...
Foresite Lab’s Investment Strategy
Просмотров 169 часов назад
Foresite Labs’ Vik Bajaj, Ph.D., cofounder of Xiara Therapeutics, describes why large-scale experiments need large-scale investment like Xiara’s $1B launch. An excerpt from "A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D." - check out the full video at www.bioprocessonline.com/doc/a-b-ai-bet-with-foresite-labs-vik-bajaj-ph-d-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast...
Why Big Data Is The Key To Accelerating Drug Development
Просмотров 169 часов назад
Why Big Data Is The Key To Accelerating Drug Development
Why Foresite Labs Is Betting On AI/ML To Revolutionize Drug Development
Просмотров 309 часов назад
Why Foresite Labs Is Betting On AI/ML To Revolutionize Drug Development
How Does A Successful Client-CDMO Partnership Meet Challenges?
Просмотров 59 часов назад
How Does A Successful Client-CDMO Partnership Meet Challenges?
Engaging A CDMO Partner With Life Biosciences' Jerry McLaughlin
Просмотров 49 часов назад
Engaging A CDMO Partner With Life Biosciences' Jerry McLaughlin
Life Biosciences’ Successful Partnership With Forge Biologics
Просмотров 69 часов назад
Life Biosciences’ Successful Partnership With Forge Biologics
From Formulation Scientist To Biotech Founder And CEO
Просмотров 512 часов назад
From Formulation Scientist To Biotech Founder And CEO
What’s Up And Coming At Revolo Biotherapeutics?
Просмотров 1012 часов назад
What’s Up And Coming At Revolo Biotherapeutics?
Optimizing Peptide Delivery With Revolo's Woody Bryan, Ph.D.
Просмотров 612 часов назад
Optimizing Peptide Delivery With Revolo's Woody Bryan, Ph.D.
Why Allan Shaw Is Optimistic About The Industry’s Future
Просмотров 1412 часов назад
Why Allan Shaw Is Optimistic About The Industry’s Future
What Will The M&A Landscape Look Like Next Year?
Просмотров 3412 часов назад
What Will The M&A Landscape Look Like Next Year?
How Will The Incoming Administration Affect The Pharmaceutical Industry?
Просмотров 1212 часов назад
How Will The Incoming Administration Affect The Pharmaceutical Industry?
Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.
Просмотров 3114 часов назад
Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.
Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.
Просмотров 13621 час назад
Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.
Biotech Story Time With Tal Zaks, M.D. (Part 1)
Просмотров 49214 дней назад
Biotech Story Time With Tal Zaks, M.D. (Part 1)
Can Gene Therapy Be the Solution for CHF with AskBio's Dr. Lothar Roessig
Просмотров 3714 дней назад
Can Gene Therapy Be the Solution for CHF with AskBio's Dr. Lothar Roessig
Ma'am could u please tell me how many numbers of si rna is discovered for COVID till the date and could u please mention those name of si rna please ma'am it's urgent.
Humacyte got their FDA approval ... DOD will be placing orders soon!! .. stock will explode! .. then in the pipeline is the cure for type 1 Diabetes, their PATENTED BioVascular Pancreas. So far, few seem to know what is coming with this forgotten company.
Amazing stuff. I’m a shareholder and appreciate the info.
What about type 2 !!!!!!
Thomas Matthew Rodriguez Elizabeth Taylor Melissa
Lewis Charles Moore Gary Young Timothy
Harris Brian Clark Linda Hall Steven
You need to call palantir, they will help you get to the next level. Palantir is the best product for your journey!! Gl
Useful info
Very Useful
Amazing technology - so close to prime time!!
Why she sold
Such a mystery !
Is it possible to access this stream in it's entirety? This channel is a gem!
‘For us, therefore, we’re really taking that leap - us as company, Bayer, in cell and gene therapy, which to me is one of these examples where really we’re going to make a difference, hopefully, moving forward. Ultimately the mRNA vaccines are an example for that - cell and gene therapy - I always like to say that if we had surveyed two years ago in the public, “would you be willing to take a gene or cell therapy and inject it into your body” - we would have had probably a 95% refusal rate. I think this pandemic has also opened many people’s eyes to innovation in a way that was maybe not possible before.’ - Bayer Executive Stefan Oelrich, in a speech at the World Health Summit, October 2021.
Biotech industry is engaged in production of only mAbs & earning money and not altering the microbiom.
GOOD JOB!
My son is off to sickkids hospital in Toronto in 2 weeks to receive his car-t cell treatment. He had ALL leukimia nearly 7 years ago and he relapsed. He is the the sweetest down syndrome kid you could ever meet. I can not thank Mr Carl June enough for giving us the oppurtunity to see our son live a normal life. If Dr. june and his team does not win a nobel prize for this, then the world needs a reset. This man is a God sent angel for sure. It would be a pleasure to shake this mans hand.
Gracias, esperamos pronto buenas noticias Afectado pde6a
Foreshadowing of his current vibrant presidential campaign.
Very on point questions, insightful.
hello sir thanks lot for this awesome conversation (jackpot of knowledge).
This really was completely useless
Very refreshing interview! Nice to hear a CEO of a biotech talk like a regular person excited about her company compared to these other CEO's I have listened to recently who drone on and sound like they are reading a script and a boring one at that. Dr. Sullivan sounds highly motivated and I can imagine it is / will be relatively easy for her to close future deals with large pharma. And her experience and great success with Springworks Therapeutics should engender confidence in her ability to run PYXS. PYXS presently trading at less than half of their cash value and looks to be an incredible bargain at the present stock price!
*You Did Not Choose To Be Classified As Diabetic, But You Can Choose To Fight Back Against Diabetes* 💪
Cocuklara uygulanırmi ne kadar olur fiyatı sizce
Eai comment ta kora bandho kor baler...
Incredibly great interview. Now a huge Cidera and Matt Pillar fan.
Times used to be very Challenging, I had the worst days of my life living with Type 2 diabetes, I appreciate you so much Dr Igudia, You have restored me my life that was lost already . Thank you so much for curing me of my diabetes with your natural Herbs 😊
Send blive details
Abslotely
I would really like to be a patient for this clinic trial as I am a T1D for 11 1/2 yrs
How is the treatment? Are you satisfied of this treatment? Now are you independent from insulin injection? Please reply me it's very important
Nothing is done since the interview. Telling story ain't cut it, it is time to execute it.
This dude said a whole lot of nothing . He can talk forever and say absolutely nothing
No cure no cure no cure 😢
They have a cure, 3 people are insulin free, 1 lady has been insulin free for over 2 years and counting, just have to get the fda to fast track what there doing
Hi sir iam living to one of belive , iam counting for days when will stem cell cure diabets
Congratulations Michelle and your team for the great achievements within the short period of time!
All the blessings and powers to you, God bless. All T1D people are going to thank and bless you throughout their lives.
Which Hospital Available Stem cell therepy T1dibetes in India...
Go to dr .sagar jawala jalgon mhararastra
God help you, God help you, I saw that you are working for us with DT1, we are not living, we are surviving, dependent on the insulin that saved us, please, please, help, respect
A very much oversold stock...IO102-103 with 3 years survival probability of >70%..this is much better than recently approved opduolag and nivo/ipi combo
silencing rnai is a Reversible and natural occurrence... homeostatic medicine. Silence, the abnormal protein and let the body heal itself.
It is nice to see this Nobel- prize winning technology leading to drugs….very promising!
I want to Share This testimony. And also thanking God For Saving my life Through #DrAlaka Who Cures All kinds Of Deadly Virus. With is Gift Of Herbal remedy. Want to say a big thanks to you #DrAlaka for saving me from Anemia Virus that I have suffer for long Now with your herbal Remedy. God Bless you Sir. Add on RUclips @ #drAlaka or through👉ruclips.net/channel/UCmkfwnFpXrrsHSxXmdgmCLg .....
this channel adds straight value. i wish i could listen live. thank you so much for uploading this
I'm surprise this discussion viewed LNP mRNA as full mRNA only. Moderna's current Personalized Cancer Vaccine mRNA-4157 Phase 2 focuses on neoantigens cleaved by proteasome in the cell. The Neoantigen Protein Chain does not seem like a major size problem. I think this discussion was not very balanced. I see the value of Car-T and cas9 but I'm not sure they compete with LNP mRNA approaches that much.
They will get bought out or bleed out. Hope mgmt makes right decision here.
ƤRO𝓂O𝕤ᗰ 🙂
What is the name of that documentary?
I'm Holden, but not golden. 🌝 . Let's moon this B word, my queens of the biosciences.💗...😁🌝
ruclips.net/video/K4pYemga4Cs/видео.html ?
Great discussion
Thank you great work
I predict a Nobel Prize for Dr. Laura Niklason!
The Russian Sputnik V vaccine demonstrates effective protection against the COVID-19 omicron strain and a higher antibody titer compared to two injections of the American Pfizer vaccine. This is evidenced by the results of a study by the Spallanzani Institute in Italy, the results of which were published in the medical journal Vaccines, the Gamaleya National Research Center for Epidemiology and Microbiology reported. It is known that the titer of virus-neutralizing antibodies to omicron in Sputnik V turned out to be 2.1 times higher in general and 2.6 times higher three months after vaccination. Thus, 74.2 percent of all blood serum samples vaccinated with the domestic drug neutralized omicron (against 56.9 percent from Pfizer). Experts found that Sputnik V generates a stronger response due to a wider range of virus-neutralizing antibodies, a heterogeneous vaccine scheme, and a higher degree of infection imitation by the adenoviral platform. It is noted that the study was conducted under equal laboratory conditions at the Spallanzani Institute on the basis of comparable serum samples from individuals vaccinated with Sputnik V and Pfizer with similar levels of IgG antibodies and virus-neutralizing activity to the original strain registered in Wuhan, China.
The Ring Therapeutics has been facing many scientific challenges over the years in regards of generating the human anellovirus therapeutic vectors; human anelloviruses seem to be some kind of evolving viruses or week like viruses - anellovirueses do not have endogenous-own viral replicase proteins, a known DNA conserved origin of replication stem loop, and indeed they form very unstable capsid virions. The potential therapeutic payload of a recombinant TTMV-Anellovirus vector may be very limited around 2000bp in size. Here, we talk about a possibility of the first generation anellovirus vectors based on scientific academy papers published many years ago….